by Elena Iemma | Apr 3, 2024 | Events
For the first time, EpiVax is hosting two back-to-back seminars in one of our favorite cities: Tokyo, Japan. Join us at the Westin Hotel Tokyo on Thursday, Friday or both! As always, participation is free of cost and will include networking receptions at the close of...
by Elena Iemma | Mar 29, 2024 | Featured, News
PROVIDENCE, RI, April 1, 2024 /PRNewswire/ — In the pursuit of developing novel biologic entities, scientists harnessing the power of AI and generative biology depend on computational tools for predicting and managing immunogenicity risk – a critical...
by Elena Iemma | Feb 22, 2024 | Thinking Out Loud -Blog
Immunogenicity assessment is key to drug safety. Currently there is no standard approach to the In Silico Immunogenicity Assessment of Therapeutic Peptides, however, the EpiVax team has worked with the FDA to develop several methods, including a validated in silico...
by Elena Iemma | Nov 2, 2023 | Thinking Out Loud -Blog
See you in Munich… or Amsterdam! Before we get to the scary stuff, have you registered for the 9th annual Amsterdam Immunogenicity and Tolerance Seminar yet? We have an amazing line up of talks planned (see details here). A range of speakers from Cardiff and the...
by Elena Iemma | Apr 4, 2023 | Events, Featured
Thank you to everyone who participated in the 9th annual Amsterdam Immunogenicity and Tolerance Seminar! The day would not have been such a success without you. Check out these photos from the event. A special thanks to the Seminar organizing committee: Corine...